IL153200A0 - PHARMACEUTICAL COMPOSITIONS COMPRISING A gOBG3 - Google Patents

PHARMACEUTICAL COMPOSITIONS COMPRISING A gOBG3

Info

Publication number
IL153200A0
IL153200A0 IL15320001A IL15320001A IL153200A0 IL 153200 A0 IL153200 A0 IL 153200A0 IL 15320001 A IL15320001 A IL 15320001A IL 15320001 A IL15320001 A IL 15320001A IL 153200 A0 IL153200 A0 IL 153200A0
Authority
IL
Israel
Prior art keywords
muscle
methods
related diseases
disorders
gobg3
Prior art date
Application number
IL15320001A
Other languages
English (en)
Original Assignee
Genset Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset Sa filed Critical Genset Sa
Publication of IL153200A0 publication Critical patent/IL153200A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15320001A 2000-05-31 2001-05-22 PHARMACEUTICAL COMPOSITIONS COMPRISING A gOBG3 IL153200A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20825100P 2000-05-31 2000-05-31
US23973500P 2000-10-11 2000-10-11
PCT/IB2001/001126 WO2001092330A2 (en) 2000-05-31 2001-05-22 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation

Publications (1)

Publication Number Publication Date
IL153200A0 true IL153200A0 (en) 2003-07-06

Family

ID=26903041

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15320001A IL153200A0 (en) 2000-05-31 2001-05-22 PHARMACEUTICAL COMPOSITIONS COMPRISING A gOBG3
IL153200A IL153200A (en) 2000-05-31 2002-12-01 USE OF gOBG3 FOR PREPARATION OF A MEDICAMENT FOR TREATING MUSCLE CELL DISORDERS

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL153200A IL153200A (en) 2000-05-31 2002-12-01 USE OF gOBG3 FOR PREPARATION OF A MEDICAMENT FOR TREATING MUSCLE CELL DISORDERS

Country Status (9)

Country Link
US (2) US7405193B2 (xx)
EP (1) EP1294866B1 (xx)
JP (1) JP2003535104A (xx)
AT (1) ATE464378T1 (xx)
AU (2) AU781253B2 (xx)
CA (1) CA2410758A1 (xx)
DE (1) DE60141827D1 (xx)
IL (2) IL153200A0 (xx)
WO (1) WO2001092330A2 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1506229A1 (en) * 2002-05-17 2005-02-16 Serono Genetics Institute S.A. Obg3 fragments inhibiting the conversion of active obg3 into less active obg3 and other compositions for treatment of metabolic disorders
WO2004083432A1 (en) 2003-03-21 2004-09-30 Academisch Ziekenhuis Leiden Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
US20050266464A1 (en) * 2004-05-21 2005-12-01 Xencor, Inc. C1q family member proteins with altered immunogenicity
ATE524547T1 (de) 2006-08-11 2011-09-15 Prosensa Technologies Bv Einzelsträngige oligonukleotide, welche komplementär zu repetitiven elementen sind, zur behandlung von dns-wiederholungen-instabilitäts- assoziierten erkrankungen
CA2693048C (en) * 2007-07-12 2016-10-18 Prosensa Technologies B.V. Molecules for targeting compounds to various selected organs or tissues
AU2008273094B2 (en) * 2007-07-12 2013-05-09 Prosensa Technologies B.V. Molecules for targeting compounds to various selected organs, tissues or tumor cells
USRE48468E1 (en) 2007-10-26 2021-03-16 Biomarin Technologies B.V. Means and methods for counteracting muscle disorders
CA2704049A1 (en) 2007-10-26 2009-04-30 Academisch Ziekenhuis Leiden Means and methods for counteracting muscle disorders
EP2088156A1 (en) 2008-02-08 2009-08-12 Institut Pasteur Use of adiponectin for the diagnosis and/or treatment of presbycusis
EP2119783A1 (en) 2008-05-14 2009-11-18 Prosensa Technologies B.V. Method for efficient exon (44) skipping in Duchenne Muscular Dystrophy and associated means
AU2010239779A1 (en) 2009-04-24 2011-11-17 Prosensa Technologies B.V. Oligonucleotide comprising an inosine for treating DMD
AU2010335039B2 (en) 2009-12-24 2015-03-26 Academisch Ziekenhuis Leiden H.O.D.N. Lumc Molecule for treating an inflammatory disorder
CN104203289B (zh) 2012-01-27 2020-11-03 比奥马林技术公司 用于治疗杜兴型肌营养不良症和贝克型肌营养不良症的具有改善特性的rna调节性寡核苷酸
KR101438744B1 (ko) * 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
JP6539511B2 (ja) * 2015-06-17 2019-07-03 花王株式会社 運動機能の判定用マーカー
NL2015032B1 (en) 2015-06-26 2017-01-24 Vitalnext B V Compositions and methods for the treatment of malnutrition.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869330A (en) 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
FR2767135B1 (fr) * 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
DE69837678T2 (de) * 1997-10-29 2007-12-27 Otsuka Pharmaceutical Co., Ltd. Compositions zur inhibierung der proliferation glatter muskulatur und verfahren zur diagnose von arteriosklerose
US6566332B2 (en) * 2000-01-14 2003-05-20 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
DK1248849T3 (da) * 2000-01-14 2008-12-08 Serono Genetics Inst Sa Globulært OBG3-hoved og anvendelser deraf til reduktion af kropsmasse
US6579852B2 (en) * 2000-01-14 2003-06-17 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
US20020058617A1 (en) * 2000-01-14 2002-05-16 Joachim Fruebis OBG3 globular head and uses thereof for decreasing body mass
US7338787B2 (en) * 2000-01-14 2008-03-04 Serono Genetics Institute S.A. Nucleic acids encoding OBG3 globular head and uses thereof
US6989367B2 (en) * 2000-01-14 2006-01-24 Genset S.A. OBG3 globular head and uses thereof
WO2002060466A2 (en) * 2001-02-02 2002-08-08 Genset S.A. Gssp3 polynucleotides and polypeptides and uses thereof
US6867189B2 (en) * 2001-07-26 2005-03-15 Genset S.A. Use of adipsin/complement factor D in the treatment of metabolic related disorders
US20050065079A1 (en) * 2001-10-12 2005-03-24 Aaron Scalia Ngzipa,ngzipd,pgzipa and pgzipd polynucleotides and polypeptides and uses thereof

Also Published As

Publication number Publication date
IL153200A (en) 2010-05-17
US20080274971A1 (en) 2008-11-06
EP1294866A2 (en) 2003-03-26
US7405193B2 (en) 2008-07-29
DE60141827D1 (de) 2010-05-27
EP1294866B1 (en) 2010-04-14
AU2005203365B2 (en) 2008-02-14
AU2005203365A1 (en) 2005-08-25
ATE464378T1 (de) 2010-04-15
AU7439801A (en) 2001-12-11
AU781253B2 (en) 2005-05-12
US20060035824A1 (en) 2006-02-16
CA2410758A1 (en) 2001-12-06
WO2001092330A2 (en) 2001-12-06
JP2003535104A (ja) 2003-11-25
WO2001092330A3 (en) 2002-08-22

Similar Documents

Publication Publication Date Title
IL153200A0 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING A gOBG3
GEP20053510B (en) Substituted Pyrrolopyridinone Derivatives Useful as Phosphodiesterase Inhibitors
CA2303498A1 (en) Dioxocyclopentyl hydroxamic acids
MY142029A (en) Phenoxyacetic acid derivatives
HUP0001539A2 (hu) 2-(1-Imino-etil-amino)-etil-homocisztein, eljárás előállítására és az ezt tartalmazó gyógyszerkészítmények
AU6720000A (en) New process for the preparation of conjugated linoleic acid (cla)
UA66745C2 (en) INTERLEUKIN-1b-CONVERTING ENZYME INHIBITORS, PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF DISEASES
CA2288445A1 (en) 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
GEP20053660B (en) Novel Tyrosine Kinase Inhibitors
MX9606546A (es) Compuestos inhibidores de la enzima conversiva de interleukina-1 beta.
ATE305296T1 (de) Zusammensetzungen und verfahren zur behandlung von abnormaler zellvermehrung
EA200602191A1 (ru) 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения
WO2003099266A3 (en) Acetamides and benzamides that are useful in treating sexual dysfunction
IL174206A0 (en) Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
DE60022230D1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
IL153147A0 (en) Phospholipid derivatives of valporic acid and mixtures thereof
FR2797186B1 (fr) Procede d'extraction d'un principe actif a partir de levures, notamment pour le traitement des rides, principe actif obtenu, compositions cosmetiques et traitement adaptes
MY166631A (en) Orally administrable composition for improving skin quality
WO2001001974A3 (en) Naaladase inhibitors in anxiety and memory disorders
RS19504A (xx) Nova jedinjenja i kompozicije kao inhibitori katepsina
HK1090354A1 (en) Novel dibenzo [b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
PL346143A1 (en) Tan-1057 derivatives
DE60026883D1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
ATE322244T1 (de) Verwendung von polyaminosäurederivaten zur behandlung von seborrhoe und verwandten hautstörungen
NZ515531A (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods